共 121 条
- [1] Lisonkova S(2013)Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease Am J Obstet Gynecol 209 544-644
- [2] Joseph KS(2010)Pre-eclampsia Lancet 376 631-622
- [3] Steegers EA(2017)Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia N Engl J Med 377 613-1798
- [4] von Dadelszen P(2007)Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet. 369 1791-556
- [5] Duvekot JJ(2012)Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis Am J Perinatol 29 551-33
- [6] Pijnenborg R(2013)Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort BMC Pregnancy Childbirth 13 110-506
- [7] Rolnik DL(2016)Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation Am J Obstet Gynecol 214 103-569
- [8] Wright D(2019)The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention Int J Gynaecol Obstet 145 1-43
- [9] Poon LC(2015)Urine proteomic studies in preeclampsia Proteomics Clin Appl 9 501-74
- [10] O'Gorman N(2008)Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia Am J Obstet Gynecol 199 551-131g